National Repository of Grey Literature 16 records found  1 - 10next  jump to record: Search took 0.00 seconds. 
The role of oxygen radicals in the early phase of exposure to hypoxia in the development of hypoxic pulmonary hypertension
Lachmanová, Věra ; Herget, Jan (advisor) ; Geršl, Vladimír (referee) ; Neckář, Jan (referee)
A pulmonary vascular bed is low-pressure system at adult subjects. Pulmonary vessels react to hypoxia by two different processes. These are hypoxic pulmonary vasoconstriction (HPV) and hypoxic pulmonary hypertension (HPH). They differ in mechanism of origin, but there seems to be important role of reactive oxygen species and nitric oxide. It was assumed in the past that HPV is isolated reaction of small pulmonary arteries to acute hypoxia and HPH to chronic hypoxia. Recently we believe that HPH is developed on the basis HPV (Crossno, Garat et al. 2007) and remodelation of peripheral pulmonary vessels (Reid 1986). Our main task was to learn, whether antioxidants given in the early phase of exposure to hypoxia influence pulmonary hypertension more than its late administration, in the period of already developed damage of pulmonary vessels. We have used N-acetyl-L-cysteine (NAC) as an antioxidant substance. We measured changes in resistance of pulmonary vascular bed, changes of reactivity of pulmonary vessels in dependence on concentration of oxygen in the inhalated air. Measurements were performed on the model of rat isolated perfused lungs. In addition we have observed influence of the early and late treatment of NAC on the pulmonary artery pressure at rats kept in hypoxic conditions. Our results show that...
Preemptive analgesia & the role of drugs affecting nervous system in potentiatio n of analgesics efficacy
Slíva, Jiří ; Kršiak, Miloslav (advisor) ; Geršl, Vladimír (referee) ; Kozák, Jiří (referee)
The aim of our research is was to determine whether new and already clinically successfullyused anticonvulsant levetiracetam has a preemptive or therapeutic effects in the model of postoperative pain in rats. The second objective of our research was to determine whether guaifenesin increases the efficiency even analgesic NSAIDs, with different selectivity for COX-2 (ibuprofen, nimesulide and celecoxib) in the model of visceral pain in mice. As Previously, it was discovered that guaifenesin increases theabsorption of paracetamol, we investigated whether guaifenesin also affect plasma levels of one of the NSAIDs tested, andnimesulide. The third main objective of our research was therefore to determine whether cannabinoid receptor agonist CP-55940 increases the analgesic activity of diclofenac in amodel of visceral pain model in mice and inflammatory pain in rat.
Pharmacological cardioprotection with iron chelators and anthracycline cardiotoxicity
Popelová, Olga ; Geršl, Vladimír (advisor) ; Fusek, Josef (referee) ; Kolář, František (referee)
In this Ph.D. thesis, following aims were addressed: 1) potentially cardioprotective effects of deferiprone on the model of daunorubicin-induced chronic cardiotoxicity in rabbits, 2) the role of apoptotic cell death in the development of anthracycline cardiotoxicity, 3) cardioprotective effects of dexrazoxane against chronic anthracycline cardiotoxicity with a focus on rescue of cardiac myocytes from programmed cell death and oxidative stress, and 4) staging of myocardial changes in the time-course of chronic anthracycline cardiotoxicity development. First, using the leukemic cell line, deferiprone (1-300 µmol/L) was shown not to blunt the antiproliferative effect of daunorubicin. Instead, at higher concentrations of deferiprone, the augmentation of antiproliferative actions of both agents was observed. However, in the cardioprotective study deferiprone failed to afford significant protection against daunorubicin-induced mortality, cardiac dysfunction, morphological cardiac deteriorations, plasma cardiac troponin T rise as well as myocardial lipoperoxidation. This finding contrasted with previous positive outcomes of in vitro studies. Hence, this study changes the current view on deferiprone as a potential cardioprotectant against anthracycline cardiotoxicity. In addition, these results, together...
Cardiac tolerance to oxygen deprivation: the effects of inhalational and intravenous anesthetics
Říha, Hynek ; Pirk, Jan (advisor) ; Bultas, Jan (referee) ; Geršl, Vladimír (referee)
Background: Surgical procedures are invariably accompanied by the use of inhalational and intravenous anesthetics. Both groups have strong influence on cardiovascular system by the interaction with myocardial oxygen supply/demand ratio and cardiomyocyte functions at the level of cell membranes, ion channels and regulatory enzymes. Aims: 1. To examine the effects of different isoflurane concentrations on the left ventricular (LV) dimensions and systolic function in the rat. 2. To examine the effects of isoflurane-induced myocardial preconditioning (APC) on the cardiac tolerance to ischemia- reperfusion (I-R) injury. 3. To compare the influence of anesthesia, based on ketamine- dexmedetomidine (KET-DEX), on the release of biochemical markers of myocardial injury and the early postoperative course with the anesthesia, based on sevoflurane-sufentanil (SEVO), in the patients undergoing coronary artery bypass grafting (CABG). Methods: 1. We carried out transthoracic echocardiographic examination in the rats immobilized by 1.5-3% concentration of isoflurane. 2. After inducing APC by isoflurane (0.5 and 1 MAC), we evaluated ventricular arrhythmias during regional ischemia (45 min), induced by the occlusion of the left anterior descending artery, and subsequent reperfusion (60 min), using the model of...
Cardiac tolerance to oxygen deprivation: the effects of inhalational and intravenous anesthetics
Říha, Hynek ; Pirk, Jan (advisor) ; Bultas, Jan (referee) ; Geršl, Vladimír (referee)
Background: Surgical procedures are invariably accompanied by the use of inhalational and intravenous anesthetics. Both groups have strong influence on cardiovascular system by the interaction with myocardial oxygen supply/demand ratio and cardiomyocyte functions at the level of cell membranes, ion channels and regulatory enzymes. Aims: 1. To examine the effects of different isoflurane concentrations on the left ventricular (LV) dimensions and systolic function in the rat. 2. To examine the effects of isoflurane-induced myocardial preconditioning (APC) on the cardiac tolerance to ischemia- reperfusion (I-R) injury. 3. To compare the influence of anesthesia, based on ketamine- dexmedetomidine (KET-DEX), on the release of biochemical markers of myocardial injury and the early postoperative course with the anesthesia, based on sevoflurane-sufentanil (SEVO), in the patients undergoing coronary artery bypass grafting (CABG). Methods: 1. We carried out transthoracic echocardiographic examination in the rats immobilized by 1.5-3% concentration of isoflurane. 2. After inducing APC by isoflurane (0.5 and 1 MAC), we evaluated ventricular arrhythmias during regional ischemia (45 min), induced by the occlusion of the left anterior descending artery, and subsequent reperfusion (60 min), using the model of...
The role of oxygen radicals in the early phase of exposure to hypoxia in the development of hypoxic pulmonary hypertension
Lachmanová, Věra ; Herget, Jan (advisor) ; Geršl, Vladimír (referee) ; Neckář, Jan (referee)
A pulmonary vascular bed is low-pressure system at adult subjects. Pulmonary vessels react to hypoxia by two different processes. These are hypoxic pulmonary vasoconstriction (HPV) and hypoxic pulmonary hypertension (HPH). They differ in mechanism of origin, but there seems to be important role of reactive oxygen species and nitric oxide. It was assumed in the past that HPV is isolated reaction of small pulmonary arteries to acute hypoxia and HPH to chronic hypoxia. Recently we believe that HPH is developed on the basis HPV (Crossno, Garat et al. 2007) and remodelation of peripheral pulmonary vessels (Reid 1986). Our main task was to learn, whether antioxidants given in the early phase of exposure to hypoxia influence pulmonary hypertension more than its late administration, in the period of already developed damage of pulmonary vessels. We have used N-acetyl-L-cysteine (NAC) as an antioxidant substance. We measured changes in resistance of pulmonary vascular bed, changes of reactivity of pulmonary vessels in dependence on concentration of oxygen in the inhalated air. Measurements were performed on the model of rat isolated perfused lungs. In addition we have observed influence of the early and late treatment of NAC on the pulmonary artery pressure at rats kept in hypoxic conditions. Our results show that...
Pharmacological cardioprotection with iron chelators and anthracycline cardiotoxicity
Popelová, Olga ; Geršl, Vladimír (advisor) ; Fusek, Josef (referee) ; Kolář, František (referee)
In this Ph.D. thesis, following aims were addressed: 1) potentially cardioprotective effects of deferiprone on the model of daunorubicin-induced chronic cardiotoxicity in rabbits, 2) the role of apoptotic cell death in the development of anthracycline cardiotoxicity, 3) cardioprotective effects of dexrazoxane against chronic anthracycline cardiotoxicity with a focus on rescue of cardiac myocytes from programmed cell death and oxidative stress, and 4) staging of myocardial changes in the time-course of chronic anthracycline cardiotoxicity development. First, using the leukemic cell line, deferiprone (1-300 µmol/L) was shown not to blunt the antiproliferative effect of daunorubicin. Instead, at higher concentrations of deferiprone, the augmentation of antiproliferative actions of both agents was observed. However, in the cardioprotective study deferiprone failed to afford significant protection against daunorubicin-induced mortality, cardiac dysfunction, morphological cardiac deteriorations, plasma cardiac troponin T rise as well as myocardial lipoperoxidation. This finding contrasted with previous positive outcomes of in vitro studies. Hence, this study changes the current view on deferiprone as a potential cardioprotectant against anthracycline cardiotoxicity. In addition, these results, together...
Pharmacological cardioprotection with iron chelators and anthracycline cardiotoxicity
Popelová, Olga ; Geršl, Vladimír (advisor) ; Fusek, Josef (referee) ; Kolář, František (referee)
In this Ph.D. thesis, following aims were addressed: 1) potentially cardioprotective effects of deferiprone on the model of daunorubicin-induced chronic cardiotoxicity in rabbits, 2) the role of apoptotic cell death in the development of anthracycline cardiotoxicity, 3) cardioprotective effects of dexrazoxane against chronic anthracycline cardiotoxicity with a focus on rescue of cardiac myocytes from programmed cell death and oxidative stress, and 4) staging of myocardial changes in the time-course of chronic anthracycline cardiotoxicity development. First, using the leukemic cell line, deferiprone (1-300 µmol/L) was shown not to blunt the antiproliferative effect of daunorubicin. Instead, at higher concentrations of deferiprone, the augmentation of antiproliferative actions of both agents was observed. However, in the cardioprotective study deferiprone failed to afford significant protection against daunorubicin-induced mortality, cardiac dysfunction, morphological cardiac deteriorations, plasma cardiac troponin T rise as well as myocardial lipoperoxidation. This finding contrasted with previous positive outcomes of in vitro studies. Hence, this study changes the current view on deferiprone as a potential cardioprotectant against anthracycline cardiotoxicity. In addition, these results, together...

National Repository of Grey Literature : 16 records found   1 - 10next  jump to record:
Interested in being notified about new results for this query?
Subscribe to the RSS feed.